1 week Ago By Defense World Staff
Sei Investments Co. acquired a new stake in Cibus, Inc. (NASDAQ:CBUS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC.
The institutional investor acquired 17,744 shares of the company’s stock, valued at approximately $49,000. Sei Investments Co. owned about 0.
07% of Cibus at the end of the most recent quarter. A number of other large investors also recently modified their holdings of CBUS. State Street Corp raised its stake in Cibus by 43.
6% in the third quarter. State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after buying an additional 93,236 shares in the last quarter. Charles Schwab Investment Management Inc.
raised its position in shares of Cibus by 14.6% during the 3rd quarter. Charles Schwab Investment Management Inc.
now owns 49,285 shares of the company’s stock worth $161,000 after acquiring an additional 6,276 shares in the last quarter. Wellington Management Group LLP purchased a new stake in Cibus during the third quarter worth approximately $111,000. Raymond James Financial Inc.
acquired a new position in Cibus in the fourth quarter valued at approximately $89,000. Finally, Commonwealth Equity Services LLC purchased a new position in Cibus in the fourth quarter valued at approximately $62,000. 33.
81% of the stock is owned by hedge funds and other institutional investors. Cibus Trading Up 7.1 %Shares of CBUS opened at $1.
81 on Friday. The stock’s 50 day moving average is $2.10 and its two-hundred day moving average is $3.
02. Cibus, Inc. has a twelve month low of $1.
40 and a twelve month high of $19.56. The firm has a market capitalization of $59.
46 million, a PE ratio of -0.08 and a beta of 1.83.
Cibus (NASDAQ:CBUS – Get Free Report) last issued its earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.
68) by ($0.19). The company had revenue of $1.
21 million for the quarter, compared to analysts’ expectations of $1.13 million. Cibus had a negative return on equity of 28.
17% and a negative net margin of 10,724.78%. On average, sell-side analysts predict that Cibus, Inc.
will post -2.96 EPS for the current year. Analyst Ratings ChangesSeveral analysts have recently weighed in on the stock.
HC Wainwright restated a “buy” rating and set a $25.00 price objective on shares of Cibus in a research report on Friday, March 21st. Canaccord Genuity Group decreased their price objective on shares of Cibus from $20.
00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd.View Our Latest Stock Report on CibusAbout Cibus (Free Report)Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties.
The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.Recommended StoriesFive stocks we like better than CibusStock Splits, Do They Really Impact Investors?Robinhood Strategies Could Be a Game-Changer for Young InvestorsWhy Are Stock Sectors Important to Successful Investing?Are These 3 Retail Stocks Oversold or Really in Trouble?What to Know About Investing in Penny StocksIONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead.
